window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 3, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Research & Development

  • Clinical Development,Drug Development,Regulatory Affairs,Research & Development,Technology and platforms

    FDA’s phase-out of mandatory animal testing: Certara’s Patrick Smith on biosimulation and the future of drug development

    The US Food and Drug Administration’s (FDA) decision to phase [...]

    July 22, 2025
  • Biologics & Biosimilars,Clinical Development,Drug Development,Partnerships & Funding,Research & Development

    Sanofi to acquire Vicebio for $1.6 billion, boosting next-generation multivalent respiratory vaccines

    Sanofi has agreed to acquire Vicebio Ltd, a biotechnology company [...]

    July 23, 2025
  • Rare Diseases,Research & Development

    Princess Royal opens new Insmed research facility in Cambridge focused on synthetic rescue

    Insmed has officially opened a new $10M, 17,000-square-foot research and [...]

    July 22, 2025
  • Artificial Intelligence,Clinical Development,Drug Development,Market Access & Commercialization,Research & Development,Technology and platforms

    Pharma’s AI tipping point: C-suite leaders move from pilots to enterprise scale

    The pharmaceutical sector is accelerating into an enterprise-scale AI future, [...]

    July 18, 2025
  • Clinical Trials,Drug Development,Rare Diseases,Research & Development

    DiaMedica reports positive phase 2 results showing DM199 reduces blood pressure in preeclampsia without placental transfer

    DiaMedica Therapeutics Inc has announced positive interim results from Part [...]

    July 18, 2025
  • Clinical Trials,Drug Development,Market Access & Commercialization,Oncology,Partnerships & Funding,Precision medicine,Regulatory Affairs,Research & Development,Technology and platforms

    Mainz Biomed targets US approval for next-gen CRC test and expands into pancreatic cancer

    Mainz Biomed says it is preparing to launch a pivotal [...]

    July 18, 2025
  • Artificial Intelligence,Clinical Trials,Real world evidence,Research & Development

    AI in research and clinical trials: Speed, accuracy, and a smarter future

    AI is rapidly transforming how clinical trials are designed, run, [...]

    July 17, 2025
Previous2627

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Sartorius launches Eveo platform targeting cell therapy manufacturing bottlenecks
    Categories: CDMOs & Manufacturing, Cell & Gene Therapy, Manufacturing, Technology and platforms
  • One-carbon partners Tempus to support TH9619 development in solid tumours
    Categories: Clinical Development, Clinical Trials, Oncology, Partnerships & Funding, Technology and platforms
  • Strong scientists: PHARMExcel’s Margaret Irwin on clinical research careers and early stage trials
    Categories: Clinical Trials, Healthcare leadership, Women in Pharma
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top